Completed PHASE4 INTERVENTIONAL 2-arm NCT01559324

Electroconvulsive Therapy (ECT) for Elderly Patients With Major Depression

Randomized Controlled Comparison of Bifrontal and Right Unilateral ECT as to Effects on Depression, Global Cognitive Function and Biomarkers.

Sponsor: Diakonhjemmet Hospital

Conditions Major Depression

Interventions ECT

Updated 5 times since 2017 Last updated: Jul 8, 2015 Started: Aug 31, 2009 Primary completion: Jul 31, 2013 Completion: Nov 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01559324, this PHASE4 trial focuses on Major Depression and remains completed. Sponsored by Diakonhjemmet Hospital, it has been updated 5 times since 2009, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Aug 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Diakonhjemmet Hospital
MD Tor Magne Bjølseth
MD Torfinn Lødøen Gaarden

Data source: Diakonhjemmet Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Oslo, Norway